Literature DB >> 25686394

Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse.

Paolo Goffredo1, Samantha M Thomas2, Michaela A Dinan1, Jennifer M Perkins3, Sanziana A Roman4, Julie A Sosa5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25686394     DOI： 10.1001/jamainternmed.2014.8020

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  13 in total

Review 1.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

Review 2.  Overuse of Health Care Services in the Management of Cancer: A Systematic Review.

Authors:  Shrujal S Baxi; Minal Kale; Salomeh Keyhani; Benjamin R Roman; Annie Yang; Antonio P Derosa; Deborah Korenstein
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

3.  Radioactive iodine in differentiated thyroid cancer: a national database perspective.

Authors:  Ryan K Orosco; Timon Hussain; Julia E Noel; David C Chang; Chrysoula Dosiou; Erik Mittra; Vasu Divi; Lisa A Orloff
Journal:  Endocr Relat Cancer       Date:  2019-10       Impact factor: 5.678

4.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Authors:  Yuri E Nikiforov; Raja R Seethala; Giovanni Tallini; Zubair W Baloch; Fulvio Basolo; Lester D R Thompson; Justine A Barletta; Bruce M Wenig; Abir Al Ghuzlan; Kennichi Kakudo; Thomas J Giordano; Venancio A Alves; Elham Khanafshar; Sylvia L Asa; Adel K El-Naggar; William E Gooding; Steven P Hodak; Ricardo V Lloyd; Guy Maytal; Ozgur Mete; Marina N Nikiforova; Vania Nosé; Mauro Papotti; David N Poller; Peter M Sadow; Arthur S Tischler; R Michael Tuttle; Kathryn B Wall; Virginia A LiVolsi; Gregory W Randolph; Ronald A Ghossein
Journal:  JAMA Oncol       Date:  2016-08-01       Impact factor: 31.777

Review 5.  Towards De-Implementation of low-value thyroid care in older adults.

Authors:  Jennifer M Perkins; Maria Papaleontiou
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-07-22       Impact factor: 3.626

6.  What's in a Name? A Cost-Effectiveness Analysis of the Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features' Nomenclature Revision.

Authors:  Vikas Mehta; Ankita Naraparaju; David Liao; Louise Davies; Bryan R Haugen; Peter A Kopp; Susan J Mandel; Yuri E Nikiforov; Douglas S Ross; Jennifer J Shin; R Michael Tuttle; Gregory W Randolph
Journal:  Thyroid       Date:  2022-01-07       Impact factor: 6.506

Review 7.  Importance of cost-effectiveness and value in cancer care and healthcare policy.

Authors:  Ravinder Kang; Philip P Goodney; Sandra L Wong
Journal:  J Surg Oncol       Date:  2016-06-22       Impact factor: 3.454

8.  Risk stratification of 282 differentiated thyroid cancers found incidentally in 1369 total thyroidectomies according to the 2015 ATA guidelines; implications for management and treatment.

Authors:  I Christakis; S Dimas; I D Kafetzis; N Roukounakis
Journal:  Ann R Coll Surg Engl       Date:  2018-02-27       Impact factor: 1.891

Review 9.  Medication overuse in oncology: current trends and future implications for patients and society.

Authors:  Stephen M Schleicher; Peter B Bach; Konstantina Matsoukas; Deborah Korenstein
Journal:  Lancet Oncol       Date:  2018-04       Impact factor: 41.316

Review 10.  Evidence for overuse of medical services around the world.

Authors:  Shannon Brownlee; Kalipso Chalkidou; Jenny Doust; Adam G Elshaug; Paul Glasziou; Iona Heath; Somil Nagpal; Vikas Saini; Divya Srivastava; Kelsey Chalmers; Deborah Korenstein
Journal:  Lancet       Date:  2017-01-09       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.